With over 400 scientists supporting this side of the drug discovery target identification and mechanistic studies, NUVISAN can help further develop and reposition drugs to serve the animal pharmaceuticals’ industry.
Our platform has been running for many years in drug rescue and drug repositioning services. NUVISAN can support target refinement and identify mechanisms of actions that may fit better the veterinary industry.
Moreover, our ability to distribute and manufacture for human drugs extends perfectly to the veterinary industry. Our added expertise in dermal drugs development is also an added advantage for any drug developed via topical administration.
NUVISAN has a long history of full integration of the drug substance and drug product services through Pharmaceutical Analysis and release testing, GMP API process development, upscaling and synthesis and Drug Formulation development and production services.
This range of services includes troubleshooting studies through the identification and isolation of impurities, which are commonplace and will help optimize the formulations.
Our Pharmaceutical Analysis and release testing teams are available across Europe and follow the GMP process to produce all requested testing, from stability through to microbiology and many more, for both drug and reference products.
Our Bioanalytical lab goes from proof of exposure to biomarkers research and development with a broad range of technologies (see platform here), from early research to late development studies
NUVISAN was built around laboratory services and our platform is now available in different locations throughout Europe. Our GxP facilities can assess pretty much all sort of biological matrices for proof of exposure and/or biomarkers, with the profiling/backend associated services.
Our Bioassay analytical platform will Small molecular entities as well as large molecules.